Jennifer Schneider, PhD profile page

Before joining Centauri Therapeutics as chief executive officer, Schneider was executive officer of North America for the Global Antibiotic Research & Development Partnership (GARDP). She has nearly twenty years of experience working with companies, universities and non-governmental organizations in the United States and around the world, providing expertise in antibiotic policy, partnering and fundraising. She participates in US and international discussions surrounding market creation, access and novel payment models. Schneider received her PhD in molecular biology from the University of Notre Dame and her MPH in epidemiology and international health from the University of Michigan.